NPI: 1477526754 · DEMOPOLIS, AL 36732 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/08/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/08/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,016 | $345K |
| 2019 | 3,115 | $172K |
| 2020 | 6,739 | $354K |
| 2021 | 5,537 | $84K |
| 2022 | 5,516 | $150K |
| 2023 | 4,553 | $216K |
| 2024 | 191 | $12K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 16,388 | 1,189 | $903K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,747 | 801 | $364K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 364 | 197 | $43K |
| J1756 | Injection, iron sucrose, 1 mg | 1,866 | 365 | $12K |
| 83970 | 334 | 284 | $6K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,081 | 240 | $2K |
| A4657 | Syringe, with or without needle, each | 553 | 487 | $1K |
| 85045 | 257 | 213 | $427.94 | |
| 82728 | 141 | 110 | $379.82 | |
| 85041 | 307 | 277 | $344.66 | |
| 85048 | 307 | 277 | $320.70 | |
| 83550 | 112 | 84 | $317.79 | |
| 83540 | 153 | 124 | $310.71 | |
| 82108 | 38 | 24 | $224.82 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 19 | 12 | $0.00 |